La demenza infantile è un termine classico in neurologia pediatrica, che ha cercato di diventare più operativo attraverso il concetto di PIND (deterioramento intellettivo e neurologico progressivo), con cui si intende racchiudere tutti i sindromi neurodegenerative dell'infanzia. Questo concetto include:

  • Presenza di regressione dello sviluppo (perdita delle capacità intellettive e degli apprendimenti già acquisiti),.
  • Progressiva (non si limita nel tempo, ma è persistente fino a quando il bambino perde tutte le sue abilità, anche le più basilari, come la deambulazione o la continenza sfinterica).
  • Generalizzata (non interessa un singolo dominio cognitivo o dello sviluppo).
  • Comparsa di sintomi e segni neurologici associati, evidenziabili attraverso l'esplorazione clinica (disturbo oculomotorio, piramidalismo, atassia, disturbi del movimento, epilessia).

Esistono test di screening mirato per escludere alcune di queste malattie, con l'obiettivo di ottenere una diagnosi precoce e anticipare l'evoluzione catastrofica che presentano.

Criteri diagnostici di PIND

Definizione del caso – deterioramento intellettivo e neurologico progressivo (registro UK PIND).

Qualsiasi bambino (con età inferiore a 16 anni all'insorgenza dei sintomi) che soddisfi tutti e tre i seguenti criteri: deterioramento progressivo per più di 3 mesi; perdita di abilità intellettive o dello sviluppo precedentemente acquisite; e comparsa di segni neurologici anormali
Esclusione
Perdita intellettiva statica (es. dopo encefalite, trauma cranico o quasi annegamento)
Includendo
Bambini che soddisfano la definizione di caso, anche se sono state formulate diagnosi neurologiche specifiche
Disturbi metabolici che portano al deterioramento neurologico
Disturbi convulsivi se associati a deterioramento progressivo
Bambini con diagnosi di disturbi neurodegenerativi che non hanno ancora manifestato sintomi
Rapporto limitato ai casi visti nell'ultimo mese, ma includendo quelli la cui condizione è iniziata precedentemente (ovvero includendo i "casi vecchi" di bambini in follow-up se visitati in quel mese)
19955111 {19955111:CLQYR5RR} 1 vancouver 50 default 3116 https://neuropediatoolkit.org/wp-content/plugins/zotpress/
%7B%22status%22%3A%22success%22%2C%22updateneeded%22%3Afalse%2C%22instance%22%3Afalse%2C%22meta%22%3A%7B%22request_last%22%3A0%2C%22request_next%22%3A0%2C%22used_cache%22%3Atrue%7D%2C%22data%22%3A%5B%7B%22key%22%3A%22CLQYR5RR%22%2C%22library%22%3A%7B%22id%22%3A19955111%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Verity%20et%20al.%22%2C%22parsedDate%22%3A%222021-03%22%2C%22numChildren%22%3A2%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%201.35%3B%20%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%20style%3D%26quot%3Bclear%3A%20left%3B%20%26quot%3B%26gt%3B%5Cn%20%20%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-left-margin%26quot%3B%20style%3D%26quot%3Bfloat%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%26quot%3B%26gt%3B1.%26lt%3B%5C%2Fdiv%26gt%3B%26lt%3Bdiv%20class%3D%26quot%3Bcsl-right-inline%26quot%3B%20style%3D%26quot%3Bmargin%3A%200%20.4em%200%201.5em%3B%26quot%3B%26gt%3BVerity%20C%2C%20Baker%20E%2C%20Maunder%20P%2C%20Pal%20S%2C%20Winstone%20AM.%20Differential%20diagnosis%20of%20progressive%20intellectual%20and%20neurological%20deterioration%20in%20children.%20Dev%20Med%20Child%20Neurol%20%5BInternet%5D.%202021%20Mar%20%5Bcited%202022%20Oct%2015%5D%3B63%283%29%3A287%26%23x2013%3B94.%20Available%20from%3A%20%26lt%3Ba%20class%3D%26%23039%3Bzp-ItemURL%26%23039%3B%20href%3D%26%23039%3Bhttps%3A%5C%2F%5C%2Fwww.ncbi.nlm.nih.gov%5C%2Fpmc%5C%2Farticles%5C%2FPMC7891454%5C%2F%26%23039%3B%26gt%3Bhttps%3A%5C%2F%5C%2Fwww.ncbi.nlm.nih.gov%5C%2Fpmc%5C%2Farticles%5C%2FPMC7891454%5C%2F%26lt%3B%5C%2Fa%26gt%3B%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%20%20%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Differential%20diagnosis%20of%20progressive%20intellectual%20and%20neurological%20deterioration%20in%20children%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Christopher%22%2C%22lastName%22%3A%22Verity%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Elaine%22%2C%22lastName%22%3A%22Baker%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Polly%22%2C%22lastName%22%3A%22Maunder%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Suvankar%22%2C%22lastName%22%3A%22Pal%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Anne%20Marie%22%2C%22lastName%22%3A%22Winstone%22%7D%5D%2C%22abstractNote%22%3A%22The%20prevalence%20of%20diseases%20causing%20childhood%20progressive%20intellectual%20and%20neurological%20deterioration%20in%20the%20UK%20is%20low%20%28approximately%200.1%5C%2F1000%20live%20births%29.There%20were%20more%20than%20220%20different%20disorders%2C%20mainly%20genetically%20determined.The%20majority%20of%20disorders%20presented%20early%20in%20childhood%3A%2081%25%20before%20the%20age%20of%205%5Cu00a0years.There%20were%20similarities%20in%20the%20disease%20spectrum%20in%20White%20and%20Pakistani%20children.%5Cn%2C%20Video%20Podcast%3A%20https%3A%5C%2F%5C%2Fyoutu.be%5C%2FQbUG-ZVJLHc%5Cn%2C%20This%20article%20is%20commented%20on%20by%20van%20Karnebeek%20on%20page%20243%20of%20this%20issue.%22%2C%22date%22%3A%222021-3%22%2C%22section%22%3A%22%22%2C%22partNumber%22%3A%22%22%2C%22partTitle%22%3A%22%22%2C%22DOI%22%3A%2210.1111%5C%2Fdmcn.14691%22%2C%22citationKey%22%3A%22%22%2C%22url%22%3A%22https%3A%5C%2F%5C%2Fwww.ncbi.nlm.nih.gov%5C%2Fpmc%5C%2Farticles%5C%2FPMC7891454%5C%2F%22%2C%22PMID%22%3A%2232970345%22%2C%22PMCID%22%3A%22PMC7891454%22%2C%22ISSN%22%3A%220012-1622%22%2C%22language%22%3A%22%22%2C%22collections%22%3A%5B%22VV74KMGP%22%5D%2C%22dateModified%22%3A%222026-05-09T06%3A10%3A39Z%22%7D%7D%5D%7D
1.
Verity C, Baker E, Maunder P, Pal S, Winstone AM. Differential diagnosis of progressive intellectual and neurological deterioration in children. Dev Med Child Neurol [Internet]. 2021 Mar [cited 2022 Oct 15];63(3):287–94. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7891454/
Pseudoregressione.

È necessario distinguere la vera regressione dalla pseudoregressione.

  • Pseudoreгреssione nelle encefalopatie statiche: Evoluzione naturale delle encefalopatie statiche, che possono presentare un peggioramento correlato alla fase dello sviluppo postpuberale, come conseguenza dei cambiamenti biologici che avvengono nell'organismo con l'arrivo dell'età adulta (peggioramento della spasticità).
  • Regressione autistica. È caratteristica nei bambini con ASD, compare tra i 18 e i 24 mesi, colpisce principalmente il linguaggio, ma non presenta una progressione successiva.
  • Pseudoregressione psicogenaSi tratta di quella perdita di tappe dello sviluppo già acquisite (come il controllo degli sfinteri) abituale nei bambini piccoli, come conseguenza di cambiamenti nell'ambiente (nascita di un fratello, ecc.), transitoria e con un innesco emotivo identificabile.
Malattie che causano PIND
Malattie lisosomali.
Malattie lisosomali che interessano il trasporto e il metabolismo dei lipidi.

• Deficit combinato di saposina (prosaposina)
• Malattia di Farber
• Malattia di Gaucher (tipo 2)
• Malattia di Gaucher (tipo 3)
• Leucodistrofia a cellule globoidi (malattia di Krabbe)
• Gangliosidosi GM1 (tipo 1 e 2)
• Gangliosidosi GM2 – variante AB
• Gangliosidosi GM2 (malattia di Tay-Sachs)
• Gangliosidosi GM2 (malattia di Sandhoff)
• Leucodistrofia metacromatica
• Deficit di solfatasi multipla
• Malattia di Niemann-Pick tipo A
• Malattia di Niemann-Pick di tipo C
• Deficit di saposina A
• Deficit di saposina B
• Deficit di saposina C

Glucoproteinosi.

• Alfa-mannosidosi
• Deficit di α-N-acetilgalattosaminidasi (malattia di Schindler (tipo I))
• Aspartilglucosaminuria (AGU)
• Beta-mannosidosi
• Fucosidosi (tipo I e II)
• Galattosialidosi (mutazione della catepsina A)
• Mucolipidosi di tipo I (sialidosi di tipo II)
• Mucolipidosi di tipo II (malattia di I-cell)
• Mucolipidosi di tipo IV

• MPS I (sindrome di Hurler)
• MPS II (sindrome di Hunter)
• MPS III (sindrome di Sanfilippo)
• MPS VII (sindrome di Sly)

Altre malattie lisosomali.

• Lipofusinosi ceroidi neuronali (NCL o malattia di Batten); 14 sottotipi (ad eccezione di quelli a esordio adulto CLN 4, 11, 13)
• Malattia da accumulo di acido sialico

Metabolismo dei lipidi.

• Abetalipoproteinemia
• Xantomatosi cerebrotendinea

Aminoacidopatie e malattie degli acidi organici.

• Malattia di Canavan
• Deficit di glutatione sintetasi
• Encefalopatia da glicina / iperglicinemia non chetotica
• Deficit di omocarnosilasi sintetasi
• Deficit di solfito ossidasi

Diagnosi differenziale.
In base ai sintomi neurologici.
Polioencefalopatie.
Leucoencefalopatie.
Encefalopatie.
Espinocerebellopatie.
In base all'età di esordio.
19955111 {19955111:ZJTIEEEK} 1 vancouver 50 default 3116 https://neuropediatoolkit.org/wp-content/plugins/zotpress/
%7B%22status%22%3A%22success%22%2C%22updateneeded%22%3Afalse%2C%22instance%22%3Afalse%2C%22meta%22%3A%7B%22request_last%22%3A0%2C%22request_next%22%3A0%2C%22used_cache%22%3Atrue%7D%2C%22data%22%3A%5B%7B%22key%22%3A%22ZJTIEEEK%22%2C%22library%22%3A%7B%22id%22%3A19955111%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Mishra%22%2C%22parsedDate%22%3A%222018-07-17%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%201.35%3B%20%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%20style%3D%26quot%3Bclear%3A%20left%3B%20%26quot%3B%26gt%3B%5Cn%20%20%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-left-margin%26quot%3B%20style%3D%26quot%3Bfloat%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%26quot%3B%26gt%3B1.%26lt%3B%5C%2Fdiv%26gt%3B%26lt%3Bdiv%20class%3D%26quot%3Bcsl-right-inline%26quot%3B%20style%3D%26quot%3Bmargin%3A%200%20.4em%200%201.5em%3B%26quot%3B%26gt%3BMishra%20S.%20Approach%20to%20Neurodegenerative%20Disease%20in%20Children%3A%20A%20Short%20Review.%20PAPN%20%5BInternet%5D.%202018%20July%2017%20%5Bcited%202021%20July%2021%5D%3B1%285%29.%20Available%20from%3A%20%26lt%3Ba%20class%3D%26%23039%3Bzp-ItemURL%26%23039%3B%20href%3D%26%23039%3Bhttps%3A%5C%2F%5C%2Fwww.lupinepublishers.com%5C%2Fpediatrics-neonatal-journal%5C%2Ffulltext%5C%2Fopenaccess-approach-to-neurodegenerative-disease-in-children-a-short-review.ID.000121.php%26%23039%3B%26gt%3Bhttps%3A%5C%2F%5C%2Fwww.lupinepublishers.com%5C%2Fpediatrics-neonatal-journal%5C%2Ffulltext%5C%2Fopenaccess-approach-to-neurodegenerative-disease-in-children-a-short-review.ID.000121.php%26lt%3B%5C%2Fa%26gt%3B%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%20%20%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Approach%20to%20Neurodegenerative%20Disease%20in%20Children%3A%20A%20Short%20Review%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Shubhankar%22%2C%22lastName%22%3A%22Mishra%22%7D%5D%2C%22abstractNote%22%3A%22Neurodegenerative%20disorders%20of%20childhood%20are%20complicated%20diseases%20with%20wide%20range%20of%20systematic%20involvement.%20These%20diseases%20often%20pose%20great%20challenge%20to%20clinicians%20in%20terms%20of%20diagnosis%20and%20management.%20The%20purpose%20of%20this%20article%20is%20to%20outline%20a%20systematic%20approach%20to%20a%20child%20presenting%20with%20suspected%20neurodevelopmental%20regression.%20Many%20inherited%20metabolic%20disorders%20present%20with%20neural%20regression.%20The%20clinical%20approach%20depends%20upon%20the%20age%20of%20presentation%2C%20site%20of%20involvement%20in%20brain.%20Sound%20clinical%20knowledge%20and%20better%20approach%20leads%20to%20early%20diagnosis%2C%20better%20management%20and%20above%20all%20genetic%20counselling.%20As%20the%20medical%20science%20is%20in%20the%20track%20of%20rapid%20progression%20several%20treatment%20modalities%20are%20in%20the%20pipeline%20for%20neurodegenerative%20syndromes%2C%20early%20diagnosis%20and%20referral%20to%20higher%20centres%20can%20bring%20a%20better%20future%20to%20the%20child.%22%2C%22date%22%3A%222018-7-17%22%2C%22section%22%3A%22%22%2C%22partNumber%22%3A%22%22%2C%22partTitle%22%3A%22%22%2C%22DOI%22%3A%2210.32474%5C%2FPAPN.2018.01.000121%22%2C%22citationKey%22%3A%22%22%2C%22url%22%3A%22https%3A%5C%2F%5C%2Fwww.lupinepublishers.com%5C%2Fpediatrics-neonatal-journal%5C%2Ffulltext%5C%2Fopenaccess-approach-to-neurodegenerative-disease-in-children-a-short-review.ID.000121.php%22%2C%22PMID%22%3A%22%22%2C%22PMCID%22%3A%22%22%2C%22ISSN%22%3A%2226374722%22%2C%22language%22%3A%22en%22%2C%22collections%22%3A%5B%22VV74KMGP%22%5D%2C%22dateModified%22%3A%222026-07-15T22%3A37%3A55Z%22%7D%7D%5D%7D
1.
Mishra S. Approach to Neurodegenerative Disease in Children: A Short Review. PAPN [Internet]. 2018 July 17 [cited 2021 July 21];1(5). Available from: https://www.lupinepublishers.com/pediatrics-neonatal-journal/fulltext/openaccess-approach-to-neurodegenerative-disease-in-children-a-short-review.ID.000121.php
Informazioni sulla sensibilizzazione.

Demenze infantili È una pagina web dedicata alla diffusione e alla sensibilizzazione su queste malattie, con l'obiettivo di sensibilizzare la popolazione e le autorità sanitarie sull'importanza dell'investimento nella ricerca per il progresso dei trattamenti di queste malattie devastanti.